#ITI#Efficacy of avian influenza vaccine in poultry: A meta-analysis#FTI#
#IRE#Vaccination is an effective method for controlling avian influenza (AI), especially in countries with endemic infection. This study conducted a Bayesian meta-analysis to evaluate the efficacy of AI vaccines in chickens. We included both inactivated and recombinant fowlpox virus expressing H5 (rFPV-H5) vaccine studies that used specific-pathogen-free chickens where outcomes against the H5N1 or H5N2 AI viruses were measured. Vaccine efficacy was evaluated by protection from mortality, protection from morbidity, reductions in virus isolation from the respiratory tract, and reductions in virus isolation from the cloaca. The efficacies for homologous inactivated vaccines by those four outcomes were 92% (95% confidence interval 90%-95%), 94% (91%-96%), 54% (50%-58%), and 88% (84%-91%), respectively. Corresponding figures for heterologous inactivated vaccines were 68% (63%-73%), 78% (74%-81%), 24% (16%-31%), and 71% (64%-77%); and efficacies for rFPV-H5 vaccine were 97% (94%-99%), 93% (90%-94%), 21% (14%-27%), and 78% (72%-84%), respectively. Although those vaccines protect chickens from morbidity and mortality, virus shedding would be an important biosecurity issue for further AI endemic control. Â© American Association of Avian Pathologists 2010.#FRE#
#IPC#AI; Bayesian meta-analysis; vaccine#FPC#
#IRF#Beard C.W., Schnitzlein W.M., Tripathy D.N., Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses, Avian Dis., 35, pp. 356-359, (1991); 
Beard C.W., Schnitzlein W.M., Tripathy D.N., Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza, Avian Dis., 36, pp. 1052-1055, (1992); 
Bublot M., Le Gros F.X., Nieddu D., Pritchard N., Mickle T.R., Swayne D.E., Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand, Avian Dis., 51, pp. 332-337, (2007); 
Bublot M., Pritchard N., Cruz J.S., Mickle T.R., Selleck P., Swayne D.E., Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge, Avian Diseases, 51, SUPPL. 1, pp. 498-500, (2007); 
Capua I., Marangon S., The use of vaccination as an option for the control of avian influenza, Avian Pathology, 32, 4, pp. 335-343, (2003); 
Capua I., Terregino C., Cattoli G., Toffan A., Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus, Avian Pathol., 33, pp. 158-163, (2004); 
Chen H., Smith G.J., Li K.S., Wang J., Fan X.H., Rayner J.M., Vijaykrishna D., Zhang J.X., Zhang L.J., Guo C.T., Cheung C.L., Xu K.M., Duan L., Huang K., Qin K., Leung Y.H., Wu W.L., Lu H.R., Chen Y., Xia N.S., Naipospos T.S., Yuen K.Y., Hassan S.S., Bahri S., Nguyen T.D., Webster R.G., Peiris J.S., Guan Y., Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control, Proc. Natl. Acad. Sci. U. S. A., 103, pp. 2845-2850, (2006); 
Congdon P., Bayesian Statistical Modeling, (2006); 
Crawford J.M., Garcia M., Stone H., Swayne D., Slemons R., Perdue M.L., Molecular characterization of the hemagglutinin gene and oral immunization with a waterfowl-origin avian influenza virus, Avian Dis., 42, pp. 486-496, (1998); 
Escorcia M., Vazquez L., Mendez S.T., Rodriguez- Ropon A., Lucio E., Nava G.M., Avian influenza: Genetic evolution under vaccination pressure, Virol. J., 24, (2008); 
Garcia A., Johnson H., Srivastava D.K., Jayawardene D.A., Wehr D.R., Webster R.G., Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection, Avian Dis., 42, pp. 248-256, (1998); 
Garske T., Clarke P., Ghani A., The transmissibility of highly pathogenic avian influenza in commercial poultry in industrialized countries, PLoS One, 2, (2007); 
Halvorson D.A., The control of H5 or H7 mildly pathogenic avian influenza: A role for inactivated vaccine, Avian Pathol., 31, pp. 5-12, (2002); 
Keawcharoen J., Oraveerakul K., Kuiken T., Fouchier R.A., Amonsin A., Payungporn S., Noppornpanth S., Wattanodorn S., Theam-Booniers A., Tantilertcharoen R., Pattanarangsan R., Arya N., Ratanakorn P., Osterhaus D.M., Poovorawan Y., Avian influenza in tigers and leopards, Emerg. Infect. Dis., 10, pp. 2189-2191, (2004); 
Kuiken T., Rimmelzwaan G., Van Riel D., Van Amerongen G., Baars M., Fouchier R., Osterhaus A., Avian influenza in cats, Science, 306, (2004); 
Kwon Y.K., Sung H.W., Joh S.J., Lee Y.J., Kim M.C., Choi J.G., Lee E.K., Wee S.H., Kim J.H., An outbreak of highly pathogenic avian influenza subtype H5N1 in broiler breeders, Korea. J. Vet. Med. Sci., 67, pp. 1193-1196, (2005); 
Leandro G., Meta-analysis in Medical Research: The Handbook for the Understanding and Practice of Meta-analysis., (2005); 
Lee C.W., Senne D.A., Suarez D.L., Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus, J. Virol., 78, pp. 8372-8381, (2004); 
Lee C.W., Senne D.A., Suarez D.L., Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza, Vaccine, 22, pp. 3175-3181, (2004); 
Liu M., Wood J.M., Ellis T., Krauss S., Seiler P., Johnson C., Hoffmann E., Humberd J., Hulse D., Zhang Y., Webster R.G., Perez D.R., Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics, Virology, 314, pp. 580-590, (2003); 
Naeem K., Hussain M., An outbreak of avian influenza in poultry in Pakistan, Vet. Rec., 137, (1995); 
Nishiguchi A., Yamamoto T., Tsutsui T., Sugizaki T., Mase M., Tsukamoto K., Ito T., Terakado N., Control of an outbreak of highly pathogenic avian influenza, caused by the virus sub-type H5N1, Rev. Sci. Tech., 24, pp. 933-944, (2005); 
OIE/FAO International Scientific Conference on Avian Influenza [Internet]; 
Update on Highly Pathogenic Avian Influenza in Animals (Type H5 and H7) [Internet]; 
Qiao C., Tian G., Jiang Y., Li Y., Shi J., Yu K., Chen H., Vaccines developed for H5 highly pathogenic avian influenza in China, Ann. N. Y. Acad. Sci., 1081, pp. 182-192, (2006); 
Savill N.J., St. Rose S.G., Keeling M.J., Woolhouse M.E., Silent spread of H5N1 in vaccinated poultry, Nature, 442, (2006); 
Scargle J.D., Publication bias: The "file-drawer" problem in scientific inference, J. Sci. Explor., 14, 1, pp. 91-106, (2000); 
Spickler A.R., Trampel D.W., Roth J.A., The onset of virus shedding and clinical signs in chickens infected with high-pathogenicity and low-pathogenicity avian influenza viruses, Avian Pathol., 37, 6, pp. 555-577, (2008); 
Stone H.D., Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza, Avian Dis., 37, pp. 399-405, (1993); 
Swayne D.E., Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: Emphasis on Asian H5N1 high pathogenicity avian influenza, Ann. N. Y. Acad. Sci., 1081, pp. 174-181, (2006); 
Swayne D.E., Beck J.R., Garcia M., Stone H.F., Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines, Avian Pathol., 28, pp. 245-255, (1999); 
Swayne D.E., Beck J.R., Mickle T.R., Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus, Avian Dis., 41, pp. 910-922, (1997); 
Swayne D.E., Beck J.R., Perdue M.L., Beard C.W., Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza, Avian Dis., 45, pp. 355-365, (2001); 
Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L., Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, 18, pp. 1088-1095, (2000); 
Swayne D.E., Lee C.W., Spackman E., Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus, Avian Pathol., 35, pp. 141-146, (2006); 
Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H., Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics, Virology, 341, pp. 153-162, (2005); 
Tiensin T., Chaitaweesub P., Songserm T., Chaisingh A., Hoonsuwan W., Buranathai C., Parakamawongsa T., Premashthira S., Amonsin A., Gilbert M., Nielen M., Stegeman A., Highly pathogenic avian influenza H5N1, Thailand 2004, Emerg. Infect. Dis., 11, pp. 1664-1672, (2005); 
Van Der Goot J.A., Van Boven M., Stegeman A., Water De Van S.G., De Jong M.C., Koch G., Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine, Virology, 382, pp. 91-97, (2008); 
Webster R.G., Kawaoka Y., Taylor J., Weinberg R., Paoletti E., Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens, Vaccine, 9, pp. 303-308, (1991); 
Webster R.G., Taylor J.J., E. Rivera, and E. Paoletti. Immunity to Mexican H5N2 Avian Influenza Viruses Induced by A Fowl pox-H5 Recombinant. Avian Dis., 40, pp. 461-465, (1996); 
Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T., The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens, Virology, 351, pp. 303-311, (2006); 
Avian Influenza: H5N1 Detected in Pigs in China [Internet]; 
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) [Internet], (2009)#FRF#
